✦ LIBER ✦

Management of non-resectable (stage III) breast cancer

✍ Scribed by Robert W Sponzo; Thomas J Cunningham; Richard R Caradonna; Richard Antemann

Publisher: Elsevier Science
Year: 1979
Tongue: English
Weight: 385 KB
Volume: 5
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(79)90752-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of stage III breast cancer

✍ William L. McGuire; Martin D. Abeloff; Gabriel N. Hortobagyi; Sandra M. Swain 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 868 KB

Resection of stage III non-small cell lu

Resection of stage III non-small cell lung cancer following induction therapy

✍ Valerie W. Rusch 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 779 KB

Approximately 25%-30% of all patients with non-small cell lung cancer (NSCLC) present with stage III tumors. Except for specific subsets, these tumors are not usually amenable to complete surgical resection and are associated with a 5-year survival of 10% or less. Because patients with stage III NSC

Staging and management of lung cancer: S

Staging and management of lung cancer: Sleeve resection

✍ Jean Deslauriers; Reza John Mehran; Chantai Guimont; Jacques Brisson 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 765 KB

Surgical management of stage I and stage

Surgical management of stage I and stage II breast cancer

✍ David W. Kinne 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB

Patients with Stage I or I1 breast cancer are candidates for either modified radical mastectomy or breast preservation, with limited resection of the primary, axillary dissection, and breast irradiation. Overall survival rates with these two approaches are comparable in retrospective reviews and in

Management of stage III primary breast c

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

✍ Gabriel N. Hortobagyi; F. C. Ames; A. U. Buzdar; S. W. Kau; M. D. McNeese; D. Pa 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 970 KB

One hundred seventy-four evaluable patients with noninflammatory Stage III (both operable and inoperable) breast cancer were treated with a combined modality strategy between 1974 and 1985. All patients received combination chemotherapy with 5-fluorouracil, Adriamycin (doxorubicin), and cyclophospha

Prognostic indicators in stage III and l

Prognostic indicators in stage III and localized stage IV breast cancer

✍ D. Venkata Rao; John Bedwinek; Carlos Perez; Jeannette Lee; Barbara Fineberg 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB